NIKKEI 225
27,008.57 -122.77 (-0.45%) HANG SENG
24,242.11 -1.50 (-0.01%) CRUDE OIL
85.32 -0.28 (-0.33%) GOLD FUTURES
1,847.80 -4.70 (-0.25%) DOW
34,297.73 -66.77 (-0.19%) BTC-GBP
27,871.62 +1,036.53 (+3.86%)
Publicis Groupe S.A. (PUBGY)
| Previous close | 17.07 |
| Open | 16.30 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 16.15 - 16.36 |
| 52-week range | 12.33 - 17.84 |
| Volume | |
| Avg. volume | 40,598 |
| Market cap | 16.238B |
| Beta (5Y monthly) | 1.00 |
| PE ratio (TTM) | 16.54 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.59 (3.41%) |
| Ex-dividend date | 15 Jun 2021 |
| 1y target est | N/A |
- Reuters
Publicis loses bid to escape Massachusetts opioid marketing lawsuit
BOSTON (Reuters) -A unit of French advertising company Publicis Groupe SA on Friday lost a bid to dismiss a lawsuit by Massachusetts' attorney general claiming it helped OxyContin maker Purdue Pharma LP fuel the U.S. opioid epidemic. Publicis Health had called Attorney General Maura Healey's lawsuit an unprecedented attempt to sue an advertising agency over a manufacturer's marketing of its products. But Suffolk County Superior Court Judge Brian Davis said Healey brought "non-speculative" claims under the state's public nuisance law and consumer protection statute that could move forward.
- Bloomberg
Snap Warning Feeds Concerns Over Social Media Ad Splurge
(Bloomberg) -- A warning from Snap Inc. is rattling technology investors who have got used to turbocharged growth in ad spending on social media. Most Read from BloombergA Deep Dive Into Squid Game's World of InequalityMeet Six People Fighting Water Scarcity Across the GlobeHamburg Is at the Heart of Germany’s Growing Dilemma Over ChinaExecutives from the maker of Snapchat said Thursday that supply-chain bottlenecks are prompting companies to hold back on online ad spend for the upcoming holiday
- Investing.com
Publicis Gains on Lifting Guidance as All Markets Grow Double-Digit
By Dhirendra Tripathi
